Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date14 Nov 2020 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date24 Feb 2020 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date12 May 1995 |
100 Clinical Results associated with Jilin Changyuan Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Jilin Changyuan Pharmaceutical Co., Ltd.
100 Deals associated with Jilin Changyuan Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Jilin Changyuan Pharmaceutical Co., Ltd.